Precigen to Participate in the 2022 Wells Fargo Healthcare Conference
GERMANTOWN, Md., Sept. 1, 2022 /PRNewswire/ — Precigen, Inc. (NASDAQ: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will…
Comments Off on Precigen to Participate in the 2022 Wells Fargo Healthcare Conference